Literature DB >> 22085810

A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies.

M Brandl1, K Strobl, J Hartmann, K Kellner, T Posnicek, D Falkenhagen.   

Abstract

BACKGROUND: Citrate anticoagulation offers several advantages in comparison to conventional anticoagulation. Most algorithms for regional citrate-calcium anticoagulation are based on citrate and calcium chloride infusion coupled in a fixed proportion to the blood flow without considering the hematocrit (Hct)/plasma flow or the filter clearance of citrate and calcium.
METHODS: The aim of this study was to develop an algorithm for optimized citrate anticoagulation in extracorporeal therapies such as dialysis. A mathematical model was developed to calculate the volume of citrate infusion required to achieve a desired ionized calcium (iCa) target level in the extracorporeal circuit and to restore the total calcium level to a physiological value.
RESULTS: The model was validated by correlation analyses for different blood Hct values and shows an excellent fit to the laboratory measurements.
CONCLUSION: The results for both iCa target concentrations, namely those after citrate and calcium infusion, proved that the software algorithm adapts well to variable treatment parameters.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085810     DOI: 10.1159/000332394

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

Review 1.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

2.  Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Laura Zeppilli; Francesca Polistena; Emanuela Strampelli; Alessandro Pierucci
Journal:  Crit Care       Date:  2012-06-27       Impact factor: 9.097

3.  Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.

Authors:  Shan Huang; Kerstin Sandholm; Nina Jonsson; Anders Nilsson; Anders Wieslander; Gunilla Grundström; Viktoria Hancock; Kristina N Ekdahl
Journal:  Clin Kidney J       Date:  2014-12-01

4.  Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.

Authors:  Yuen Henry Jeffrey; Shum Hoi-Ping; Anne Leung Kit Hung; Lam Chung-Ling; Yan Wing-Wa; Lai King-Yiu
Journal:  Indian J Crit Care Med       Date:  2017-01

Review 5.  Dialysis Procedures Alter Metabolic Conditions.

Authors:  Bernd Stegmayr
Journal:  Nutrients       Date:  2017-05-27       Impact factor: 5.717

6.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Authors:  Heleen M Oudemans-van Straaten; Marlies Ostermann
Journal:  Crit Care       Date:  2012-12-07       Impact factor: 9.097

7.  An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.

Authors:  Malin S E Skagerlind; Bernd G Stegmayr
Journal:  Eur J Clin Pharmacol       Date:  2017-12-02       Impact factor: 2.953

8.  Impact of anion exchange adsorbents on regional citrate anticoagulation.

Authors:  Karin Strobl; Stephan Harm; Ute Fichtinger; Claudia Schildböck; Jens Hartmann
Journal:  Int J Artif Organs       Date:  2020-08-13       Impact factor: 1.595

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.